Immuron CEO to present company update at Emerging Growth Conference
IMC: $0.032 -13.51% · MC: $11M
Immuron said CEO Steven Lydeamore is presenting at the Emerging Growth Conference, with the accompanying presentation outlining its oral antibody platform and programs including Travelan and IMM-529. The supplied excerpt does not provide new financial or clinical updates.

Comments